Dana Investment Advisors Inc. Has $1.40 Million Position in TransMedics Group, Inc. (NASDAQ:TMDX)

Dana Investment Advisors Inc. lifted its holdings in shares of TransMedics Group, Inc. (NASDAQ:TMDX - Free Report) by 55.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 22,407 shares of the company's stock after buying an additional 8,009 shares during the period. Dana Investment Advisors Inc. owned about 0.07% of TransMedics Group worth $1,397,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of TMDX. Clear Creek Financial Management LLC acquired a new stake in TransMedics Group in the fourth quarter valued at approximately $352,000. Vaughan Nelson Investment Management L.P. lifted its stake in shares of TransMedics Group by 9.9% in the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 361,615 shares of the company's stock valued at $22,547,000 after acquiring an additional 32,605 shares during the last quarter. Baillie Gifford & Co. boosted its holdings in shares of TransMedics Group by 14.9% during the 4th quarter. Baillie Gifford & Co. now owns 269,836 shares of the company's stock valued at $16,824,000 after acquiring an additional 34,947 shares in the last quarter. State of Michigan Retirement System bought a new stake in TransMedics Group during the 4th quarter worth $6,734,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in TransMedics Group by 2.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 271,694 shares of the company's stock worth $42,656,000 after purchasing an additional 6,634 shares in the last quarter. Institutional investors and hedge funds own 99.67% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

A number of analysts have recently commented on TMDX shares. Needham & Company LLC reissued a "hold" rating on shares of TransMedics Group in a research note on Wednesday, February 5th. Robert W. Baird reduced their target price on shares of TransMedics Group from $150.00 to $120.00 and set an "outperform" rating on the stock in a report on Wednesday, December 11th. Canaccord Genuity Group restated a "buy" rating and issued a $104.00 price target on shares of TransMedics Group in a research report on Tuesday. Oppenheimer reiterated an "outperform" rating and set a $125.00 price target on shares of TransMedics Group in a report on Tuesday, December 3rd. Finally, TD Cowen decreased their price objective on TransMedics Group from $175.00 to $120.00 and set a "buy" rating for the company in a report on Monday, November 18th. Three equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, TransMedics Group has an average rating of "Moderate Buy" and a consensus target price of $122.70.

TransMedics Group Trading Down 0.8 %

Shares of TMDX stock traded down $0.57 during mid-day trading on Wednesday, hitting $67.08. The company's stock had a trading volume of 859,570 shares, compared to its average volume of 1,981,495. The company has a market cap of $2.26 billion, a PE ratio of 71.36 and a beta of 2.12. The company has a debt-to-equity ratio of 2.42, a quick ratio of 7.33 and a current ratio of 8.20. The company's fifty day simple moving average is $68.55 and its 200-day simple moving average is $95.67. TransMedics Group, Inc. has a 52 week low of $55.00 and a 52 week high of $177.37.

TransMedics Group Company Profile

TransMedics Group, Inc, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.